New insights into the use of currently available non-steroidal anti-inflammatory drugs

References

• Committee on Advancing Pain Research, Care, and Education; Institute of MedicineRelieving Pain in AmericaWashington, DC, USANational Academies Press2011
   Google Scholar
• ReidKJHarkerJBalaMMEpidemiology of chronic non-cancer pain in Europe: narrative review of prevalence, pain treatments and pain impactCurr Med Res Opin201127244946221194394
   PubMed Web of Science ®Google Scholar
• TsangAVon KorffMLeeSCommon chronic pain conditions in developed and developing countries: gender and age differences and comorbidity with depression-anxiety disordersJ Pain200891088389118602869
   PubMed Web of Science ®Google Scholar
• LeadleyRMArmstrongNLeeYCAllenAKleijnenJChronic diseases in the European Union: the prevalence and health cost implications of chronic painJ Pain Palliat Care Pharmacother201226431032523216170
   PubMedGoogle Scholar
• EadHImproving pain management for critically ill and injured patientsDynamics2005163263117725266
   PubMedGoogle Scholar
• McCarbergBHNicholsonBDToddKHPalmerTPenlesLThe impact of pain on quality of life and the unmet needs of pain management: results from pain sufferers and physicians participating in an Internet surveyAm J Ther200815431232018645331
   PubMed Web of Science ®Google Scholar
• American Society of Anesthesiologists Task Force on Acute Pain ManagementPractice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain ManagementAnesthesiology2012116224827322227789
   PubMed Web of Science ®Google Scholar
• American Society of Anesthesiologists Task Force on Chronic Pain ManagementAmerican Society of Regional Anesthesia and Pain MedicinePractice guidelines for chronic pain management: an updated report by the American Society of Anesthesiologists Task Force on Chronic Pain Management and the American Society of Regional Anesthesia and Pain MedicineAnesthesiology2010112481083320124882
   PubMed Web of Science ®Google Scholar
• BreivikHCollettBVentafriddaVCohenRGallacherDSurvey of chronic pain in Europe: prevalence, impact on daily life, and treatmentEur J Pain200610428733316095934
   PubMed Web of Science ®Google Scholar
• ConaghanPGA turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicityRheumatol Int20123261491150222193214
   PubMed Web of Science ®Google Scholar
• AtchisonJWHerndonCMRusieENSAIDs for musculoskeletal pain management: current perspectives and novel strategies to improve safetyJ Manag Care Pharm2013199 Suppl AS3S1924261788
   PubMed Web of Science ®Google Scholar
• ChouRQaseemASnowVDiagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain SocietyAnn Intern Med2007147747849117909209
   PubMed Web of Science ®Google Scholar
• HochbergMCAltmanRDAprilKTAmerican College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and kneeArthritis Care Res (Hoboken)201264446547422563589
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care ExcellenceClinical guideline 88. Low back pain: early management of persistent non-specific low back pain2009 Available from: http://www.nice.org.uk/guidance/cg88Accessed November 29, 2014
   Google Scholar
• National Institute for Health and Care ExcellenceClinical guideline 177. Osteoarthritis: care and management in adults2014 Available from: http://www.nice.org.uk/guidance/cg59Accessed Novemeber 29, 2014
   Google Scholar
• WilliamsCMMaherCGLatimerJEfficacy of paracetamol for acute low-back pain: a double-blind, randomised controlled trialLancet201438499541586159625064594
   PubMed Web of Science ®Google Scholar
• DohertyMHawkeyCGoulderMGibbIHillNAspleySReaderSA randomised controlled trial of ibuprofen, paracetamol or a combination tablet of ibuprofen/paracetamol in community-derived people with knee painAnn Rheum Dis20117091534154121804100
   PubMed Web of Science ®Google Scholar
• BruneKHinzBThe discovery and development of antiinflammatory drugsArthritis Rheum20045082391239915334450
   PubMed Web of Science ®Google Scholar
• RicciottiEFitzgeraldGAProstaglandins and inflammationArterioscler Thromb Vasc Biol2011315986100021508345
   PubMed Web of Science ®Google Scholar
• BhalaNEmbersonJMerhiAVascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trialsLancet2013382989476977923726390
   PubMed Web of Science ®Google Scholar
• García RodríguezLATacconelliSPatrignaniPRole of dose potency in the prediction of risk of myocardial infarction associated with nonsteroidal anti-inflammatory drugs in the general populationJ Am Coll Cardiol200852201628163618992652
   PubMed Web of Science ®Google Scholar
• GrosserTFriesSFitzgeraldGABiological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunitiesJ Clin Invest2006116141516395396
   PubMed Web of Science ®Google Scholar
• PatrignaniPTacconelliSBrunoASostresCLanasAManaging the adverse effects of nonsteroidal anti-inflammatory drugsExpert Rev Clin Pharmacol20114560562122114888
   PubMedGoogle Scholar
• KorotkovaMJakobssonPJCharacterization of microsomal prostaglandin E synthase 1 inhibitorsBasic Clin Pharmacol Toxicol20141141646924138533
   PubMed Web of Science ®Google Scholar
• AntmanEMBennettJSDaughertyAFurbergCRobertsHTaubertKAUse of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart AssociationCirculation2007115121634164217325246
   PubMed Web of Science ®Google Scholar
• BrunoATacconelliSPatrignaniPVariability in the response to non-steroidal anti-inflammatory drugs: mechanisms and perspectivesBasic Clin Pharmacol Toxicol20141141566323953622
   PubMed Web of Science ®Google Scholar
• PatrignaniPPanaraMRGrecoABiochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthasesJ Pharmacol Exp Ther19942713170517127996488
   PubMed Web of Science ®Google Scholar
• PatronoCCiabattoniGPincaELow dose aspirin and inhibition of thromboxane B2 production in healthy subjectsThromb Res1980173–43173277368167
   PubMed Web of Science ®Google Scholar
• Masso GonzalezELPatrignaniPTacconelliSGarcía RodríguezLAVariability among nonsteroidal antiinflammatory drugs in risk of upper gastrointestinal bleedingArthritis Rheum20106261592160120178131
   PubMed Web of Science ®Google Scholar
• FriesSGrosserTPriceTSMarked interindividual variability in the response to selective inhibitors of cyclooxygenase-2Gastroenterology20061301556416401468
   PubMed Web of Science ®Google Scholar
• PatronoCPatrignaniPGarcía RodríguezLACyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outsJ Clin Invest2001108171311435450
   PubMed Web of Science ®Google Scholar
• RaoPKnausEEEvolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyondJ Pharm Pharm Sci200811281s110s19203472
   PubMed Web of Science ®Google Scholar
• FitzgeraldGAPatronoCThe coxibs, selective inhibitors of cyclooxygenase-2N Engl J Med2001345643344211496855
   PubMed Web of Science ®Google Scholar
• SmythEMGrosserTWangMYuYFitzgeraldGAProstanoids in health and diseaseJ Lipid Res200950SupplS423S42819095631
   PubMed Web of Science ®Google Scholar
• SimmonsDLBottingRMHlaTCyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibitionPharmacol Rev200456338743715317910
   PubMed Web of Science ®Google Scholar
• MurataTUshikubiFMatsuokaTAltered pain perception and inflammatory response in mice lacking prostacyclin receptorNature199738866436786829262402
   PubMed Web of Science ®Google Scholar
• VardehDWangDCostiganMCOX2 in CNS neural cells mediates mechanical inflammatory pain hypersensitivity in miceJ Clin Invest2009119228729419127021
   PubMed Web of Science ®Google Scholar
• MeekILvan de LaarMAVonkemanHENon-steroidal anti-inflammatory drugs: an overview of cardiovascular risksPharmaceuticals2010321462162
   Google Scholar
• PatronoCBaigentCHirshJRothGAntiplatelet drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. 8th edChest20081336 Suppl199S233S18574266
   PubMed Web of Science ®Google Scholar
• HinzBChereminaOBruneKAcetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in manFASEB J200822238339017884974
   PubMed Web of Science ®Google Scholar
• AndersonBJParacetamol (acetaminophen): mechanisms of actionPaediatr Anaesth2008181091592118811827
   PubMed Web of Science ®Google Scholar
• SciulliMGSetaFTacconelliSEffects of acetaminophen on constitutive and inducible prostanoid biosynthesis in human blood cellsBr J Pharmacol2003138463464112598417
   PubMed Web of Science ®Google Scholar
• BlainHBoileauCLapicqueFLimitation of the in vitro whole blood assay for predicting the COX selectivity of NSAIDs in clinical useBr J Clin Pharmacol200253325526511874389
   PubMed Web of Science ®Google Scholar
• ReillyIAFitzgeraldGAInhibition of thromboxane formation in vivo and ex vivo: implications for therapy with platelet inhibitory drugsBlood19876911801863790723
   PubMed Web of Science ®Google Scholar
• CaponeMLTacconelliSSciulliMGHuman pharmacology of naproxen sodiumJ Pharmacol Exp Ther2007322245346017473175
   PubMed Web of Science ®Google Scholar
• KearneyPMBaigentCGodwinJHallsHEmbersonJRPatronoCDo selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trialsBMJ200633275531302130816740558
   PubMed Web of Science ®Google Scholar
• PanaraMRRendaGSciulliMGDose-dependent inhibition of platelet cyclooxygenase-1 and monocyte cyclooxygenase-2 by meloxicam in healthy subjectsJ Pharmacol Exp Ther1999290127628010381787
   PubMed Web of Science ®Google Scholar
• DovizioMBrunoATacconelliSPatrignaniPMode of action of aspirin as a chemopreventive agentRecent Results Cancer Res2013191396522893199
   PubMedGoogle Scholar
• PanaraMRPadovanoRSciulliMGEffects of nimesulide on constitutive and inducible prostanoid biosynthesis in human beingsClin Pharmacol Ther19986366726819663182
   PubMed Web of Science ®Google Scholar
• PatrignaniPPanaraMRSciulliMGSantiniGRendaGPatronoCDifferential inhibition of human prostaglandin endoperoxide synthase-1 and -2 by nonsteroidal anti-inflammatory drugsJ Physiol Pharmacol19974846236319444611
   PubMed Web of Science ®Google Scholar
• TacconelliSCaponeMLSciulliMGRicciottiEPatrignaniPThe biochemical selectivity of novel COX-2 inhibitors in whole blood assays of COX-isozyme activityCurr Med Res Opin200218850351112564662
   PubMed Web of Science ®Google Scholar
• PatrignaniPCampestriniJBransonJLumiracoxib is a selective inhibitor of cyclooxygenase-2 in patients with osteoarthritisAnn Rheum Dis2004631419142615020310
   PubMed Web of Science ®Google Scholar
• CaponeMLTacconelliSDi FrancescoLSacchettiASciulliMGPatrignaniPPharmacodynamic of cyclooxygenase inhibitors in humansProstaglandins Other Lipid Mediat2007821–4859417164136
   PubMed Web of Science ®Google Scholar
• Van HeckenASchwartzJIDepreMComparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteersJ Clin Pharmacol200040101109112011028250
   PubMed Web of Science ®Google Scholar
• HuntjensDRDanhofMla PasquaOEPharmacokinetic-pharmacodynamic correlations and biomarkers in the development of COX-2 inhibitorsRheumatology (Oxford)200544784685915855183
   PubMed Web of Science ®Google Scholar
• BruneKRennerBHinzBUsing pharmacokinetic principles to optimize pain therapyNat Rev Rheumatol201061058959820820196
   PubMed Web of Science ®Google Scholar
• BruneKFurstDECombining enzyme specificity and tissue selectivity of cyclooxygenase inhibitors: towards better tolerability?Rheumatology (Oxford)200746691191917459958
   PubMed Web of Science ®Google Scholar
• BruneKPersistence of NSAIDs at effect sites and rapid disappearance from side-effect compartments contributes to tolerabilityCurr Med Res Opin200723122985299517949535
   PubMed Web of Science ®Google Scholar
• RolfCEngstromBBeauchardCJacobsLDLe LibouxAIntra-articular absorption and distribution of ketoprofen after topical plaster application and oral intake in 100 patients undergoing knee arthroscopyRheumatology (Oxford)199938656456710402079
   PubMed Web of Science ®Google Scholar
• BensonMDAldo-BensonMBrandtKDSynovial fluid concentrations of diclofenac in patients with rheumatoid arthritis or osteoarthritisSemin Arthritis Rheum1985152 Suppl 165674081792
   PubMed Web of Science ®Google Scholar
• GoldsteinJLEisenGMLewisBGralnekIMZlotnickSFortJGVideo capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placeboClin Gastroenterol Hepatol20053213314115704047
   PubMed Web of Science ®Google Scholar
• HawkeyCBurnettIGoldMSEndoscopic evaluation of the gastro-duodenal tolerance of short-term analgesic treatment with 25 mg diclofenac-K liquid capsulesAliment Pharmacol Ther201235781982722372517
   PubMed Web of Science ®Google Scholar
• MortJRAparasuRRBaerRKInteraction between selective serotonin reuptake inhibitors and nonsteroidal antiinflammatory drugs: review of the literaturePharmacotherapy20062691307131316945053
   PubMed Web of Science ®Google Scholar
• VerbeeckRKPharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugsClin Pharmacokinet199019144662199127
   PubMed Web of Science ®Google Scholar
• AnzellottiPCaponeMLJeyamALow-dose naproxen interferes with the antiplatelet effects of aspirin in healthy subjects: recommendations to minimize the functional consequencesArthritis Rheum201163385085921360514
   PubMed Web of Science ®Google Scholar
• Catella-LawsonFReillyMPKapoorSCCyclooxygenase inhibitors and the antiplatelet effects of aspirinN Engl J Med2001345251809181711752357
   PubMed Web of Science ®Google Scholar
• RendaGTacconelliSCaponeMLCelecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart diseaseClin Pharmacol Ther200680326427416952493
   PubMed Web of Science ®Google Scholar
• MacDonaldTMWeiLEffect of ibuprofen on cardioprotective effect of aspirinLancet2003361935757357412598144
   PubMed Web of Science ®Google Scholar
• Penning-van BeestFErkensJPetersenKUKoelzHRHeringsRMain comedications associated with major bleeding during anticoagulant therapy with coumarinsEur J Clin Pharmacol2005615–643944415947920
   PubMed Web of Science ®Google Scholar
• DeviAMVargheseAKSriramSEvaluation of in vitro interactions of warfarin and duloxetine with selected coadministered nsaids in bovine serum albuminInt J Pharm Pharm Sci201131197199
   Google Scholar
• CastellsagueJRiera-GuardiaNCalingaertBIndividual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project)Drug Saf201235121127114623137151
   PubMed Web of Science ®Google Scholar
• García RodríguezLAJickHRisk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugsLancet199434389007697727907735
   PubMed Web of Science ®Google Scholar
• García RodríguezLABarrealesTLRisk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general populationGastroenterology2007132249850617258728
   PubMed Web of Science ®Google Scholar
• HinzBBruneKCan drug removals involving cyclooxygenase-2 inhibitors be avoided? A plea for human pharmacologyTrends Pharmacol Sci200829839139718606461
   PubMed Web of Science ®Google Scholar
• YuYRicciottiEGrosserTFitzgeraldGAThe translational therapeutics of prostaglandin inhibition in atherothrombosisJ Thromb Haemost20097Suppl 122222619630805
   PubMed Web of Science ®Google Scholar
• McGettiganPHenryDCardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2JAMA2006296131633164416968831
   PubMed Web of Science ®Google Scholar
• McGettiganPHenryDCardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studiesPLoS Med201189e100109821980265
   PubMed Web of Science ®Google Scholar
• BruneKDiclofenac: increase of myocardial infarctions at low doses?Pharmacoepidemiol Drug Saf201423332632824596323
   PubMed Web of Science ®Google Scholar
• OdomDMMladsiDMSaagKGRelationship between diclofenac dose and risk of gastrointestinal and cardiovascular events: meta-regression based on two systematic literature reviewsClin Ther201436690691724863260
   PubMed Web of Science ®Google Scholar
• CaponeMLTacconelliSSciulliMGClinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjectsCirculation2004109121468147115037526
   PubMed Web of Science ®Google Scholar
• GuzeyCSpigsetOGenotyping as a tool to predict adverse drug reactionsCurr Top Med Chem20044131411142115379654
   PubMed Web of Science ®Google Scholar
• ZangerUMSchwabMCytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variationPharmacol Ther2013138110314123333322
   PubMed Web of Science ®Google Scholar
• The Human Cytochrome P450 (CYP) Allele Nomenclature CommitteeThe human cytochrome P450 (CYP) allele nomenclature database2014 Available from: http://www.cypalleles.ki.se/Accessed November 29, 2014
   Google Scholar
• WolfeMMLichtensteinDRSinghGGastrointestinal toxicity of nonsteroidal antiinflammatory drugsN Engl J Med1999340241888189910369853
   PubMed Web of Science ®Google Scholar
• GibofskyASilbersteinSArgoffCDanielsSJensenSYoungCLLower-dose diclofenac submicron particle capsules provide early and sustained acute patient pain relief in a phase 3 studyPostgrad Med2013125513013824113671
   PubMed Web of Science ®Google Scholar
• American College of RheumatologyRecommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis GuidelinesArthritis Rheum20004391905191511014340
   PubMed Web of Science ®Google Scholar
• BhattDLScheimanJAbrahamNSACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus DocumentsCirculation2008118181894190918836135
   PubMed Web of Science ®Google Scholar
• JusticeECarruthersDMCardiovascular risk and COX-2 inhibition in rheumatological practiceJ Hum Hypertens20051911515385947
   PubMed Web of Science ®Google Scholar
• DixonDABlancoFFBrunoAPatrignaniPMechanistic aspects of COX-2 expression in colorectal neoplasiaRecent Results Cancer Res201319173722893198
   PubMedGoogle Scholar
• MarnettLJThe COXIB experience: a look in the rearview mirrorAnnu Rev Pharmacol Toxicol20094926529018851701
   PubMed Web of Science ®Google Scholar